Guardian article13 Sep 2021 19:05
If you read the Guardian article, yes Boots are mentioned but when you read further it says that it was with regards to a company called ReCoVa-19 that were also selling through Boots. Javid has stated that he wants to stop double jabbed people from the return PCR test when he can, but we always knew this would be the case. There is still a market for PCR tests. I would imagine Boots could possibly end their contract with the bad eggs selling through them. Penny is very insistent on good customer service and maintaining a good relationship with Boots so they can sell their other products with them, so I would expect them to be keeping on top of refunds etc. We might even find that our market share grows again with the talk of more tighter regulations etc being implemented on the PCR market.
On the market cap front, if we continued to sell £1.5m-£2m all year for the next 12 months we would have been talking closer to £100m++. Even if the PCR tests slow down to a third of the current sales we should still be way above this price, and don't forget MHC are now a company with plenty of cash to fund their new products, as well as good relationships with Boots and Lloyds Pharmacy where they will be able to expand their product range and revenue streams. DYOR